Clinical Trial

Turkish Validation of the Synkinesis Assessment Questionnaire (SAQ)

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Peripheral facial palsy may result in synkinesis, a condition characterized by involuntary facial muscle movements that occur during voluntary facial expressions. Synkinesis can negatively affect facial function, appearance, and quality of life. The Synkinesis Assessment Questionnaire (SAQ) is a patient-reported outcome measure developed to assess the severity and impact of synkinesis. However, a validated Turkish version is not currently available. The aim of this study is to translate and culturally adapt the SAQ into Turkish and to evaluate its validity and reliability in Turkish-speaking adults with peripheral facial palsy and synkinesis. The Turkish version will be developed using a standardized forward-backward translation process. Participants will complete the Turkish SAQ and the Facial Disability Index (FDI). Reliability, internal consistency, and construct validity will be evaluated to determine whether the Turkish SAQ is a valid and reliable instrument for clinical practice and research.
Trial Details
NCT Number NCT07750561
Lead Sponsor Barış CELBEK
Collaborators: Biruni University
Conditions Facial Paralysis, Facial Palsy, Bell Palsy
Enrollment 49 participants
Start Date 2026-08-15
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10